ANI Pharmaceuticals Seeks Controlled Substance Import Registration
June 05, 2025
June 05, 2025
WASHINGTON, June 5 (TNSFR) -- A notice of application from the Drug Enforcement Administration, an agency of the U.S. Department of Justice, indicates that ANI Pharmaceuticals Inc., East Windsor, New Jersey, has applied for registration as an importer of basic class controlled substances. This action serves to inform the public and initiate a period for comments and objections regarding the application.
ANI Pharmaceuticals Inc. submitted its application on April 21, 2025. The pharma . . .
ANI Pharmaceuticals Inc. submitted its application on April 21, 2025. The pharma . . .